The influence of neural blocking agents injected into the third ventricle of the rat brain and hypothalamic electrical stimulation on serum prolactin.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001835:Body Weight; D002552:Cerebral Ventricles; D004558:Electric Stimulation; D004567:Electrodes, Implanted; D005260:Female; D007031:Hypothalamus / Q000502:physiology*; D007267:Injections; D007279:Injections, Subcutaneous; D009489:Neurosecretion / Q000187:drug effects*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011388:Prolactin / Q000097:blood*; D011433:Propranolol / Q000494:pharmacology; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D013565:Sympatholytics / Q000494:pharmacology*; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D010643:Phenoxybenzamine; D001285:Atropine; D011388:Prolactin; D011433:Propranolol